A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide

Clinical Rheumatology

Volumn 30, Issue 5, 2011, Pages 607-614

  Shahin, Amira A ^a,b   El Desouky, Soha M ^a   Zayed, Hania S ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Corticosteroids; Cyclophosphamide; HCV vasculitis; Medium size vessel vasculitis; Small size vessel vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; HEPATITIS C ANTIBODY; METHYLPREDNISOLONE; STEROID; VIRUS RNA;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; BLOOD VESSEL DIAMETER; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; KIDNEY FAILURE; MALE; ORGAN INJURY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS DAMAGE INDEX; VIREMIA; VIRUS LOAD;

ADRENAL CORTEX HORMONES; ADULT; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RETROSPECTIVE STUDIES; SYSTEMIC VASCULITIS; TREATMENT OUTCOME;

EID: 79959723300     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-010-1582-4     Document Type: Article

References (45)

1. Kamal SM, Moustafa KN, Chen J, Fehr J, Abdel Moneim A, Khalifa KE, El Gohary LA, Ramy AH, Madwar MA, Rasenack J, Afdal NH (2006) Duration of peginterferon therapy in acute hepatitis C: a randomized trial. Hepatology 43(5):923-931. Erratum in: Hepatology 44(4):1055
2. Sharaf Eldin N, Ismail S, Mansour H, Rekacewicz C, El-Houssinie M, El kafrawy S, El Aidi S, Abdel-Hamid M, Esmat G, Pol S, Fontanet A, Mohamed MK (2008) Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a. www.plosone.org 3(12)
3. Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology (Suppl):S21-S29
4. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41-53
5. Cacoub P, Saadoun D, Limal N, Sene D, Lidove O, Piette JC (2005) PEGylated interferon alpha-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52:911-5 (Pubitemid 40365115)
6. Cacoub P, Saadoun D, Sene D, Limal N, Piette JC (2005) Treatment of hepatitis C virus related systemic vasculitis. J Rheumatol 32:11
7. Manns MP, McHutchison JP, Gordon SC et al (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358:958-65 (Pubitemid 32913521)
8. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P et al (2002) Interferon alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46:3317-26 (Pubitemid 35453543)
9. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E et al (2000) Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-α. J Rheumatol 27:2172-8
10. Alric L, Plaisier E, Thebault S et al (2004) Influence of antiviral therapy in hepatitis C virus associated MPGN. Am J Kidney Dis 43:617-23 (Pubitemid 38401876)
11. Casato M, Agnello V, Pucillo LP et al (1997) Predictors of longterm response to high dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus. Blood 90:3865-73 (Pubitemid 27484038)
12. Martins Junior EV, Gaburri AK, Chebli JM (2004) Cutaneous vasculitis with undetectable cryoglobulinemia in chronic hepatitis C. J Gastroenterol Hepatol 19:1220-1 (Pubitemid 39371272)
13. Levine JW, Gota C, Fessler B, Cooper SM, Calabrese L (2004) Persistent cryoglobulinemic vasculitis following successful HCV eradication (abstract). Arthritis Rheum 50:S125
14. Kimyai-Asadi A, Gohar K, Kang P, Usman A, Zeneberg R, Jih MH (2002) Mixed cryoglobulinemia secondary to interferon therapy for hepatitis C: case report and review of the literature. J Drugs Dermatol 1:72-5
15. Cacoub P, Maisonobe T, Gatel A, Servan J, Musset L, Piette JC (2001) Systemic vasculitis in patients with hepatitis C. J Rheumatol 28:109-18 (Pubitemid 32062032)
16. Rutkove SB (1997) An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a. Arch Neurol 54:907-8
17. Cid MC, Hermandez-Rodriguez J, Robert J et al (1999) Interferon-alpha may exacerbate cryoglobulinemia-related ischemic manifestations: an adverse effect potentially related to its antiangiogenic activity. Arthritis Rheum 4(2):1051-5 (Pubitemid 29215018)
18. Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D (2008) Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where we stand? Ann Rheum Dis 67:283-287
19. Naarendorp M, Kallemuchikkal U, Nuovo GJ, Gorevic PD (2001) Longterm efficacy of interferon-α for extrahepatic disease associated with hepatitis C virus infection. J Rheumatol 28:2466-73 (Pubitemid 33031978)
20. Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P (2008) Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 58:604-611 (Pubitemid 351294898)
21. Misiani R, Bellavita P, Fenili D et al (1994) Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-6 (Pubitemid 24080221)
22. Ferri C, Marzo E, Longombardo G et al (1993) Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossovercontrolled trial. Blood 81:1132-6 (Pubitemid 23067346)
23. Dammaco F, Sansonno D, Han JH et al (1994) Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 84:3336-43 (Pubitemid 24352895)
24. Ad hoc subcommittee of the American Academy of Neurology AIDS Task force (1991) Research criteria for diagnosis of chronic inflammatory demyelinating neuropathy. Neurology 41:617-618
25. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N et al (2007) Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 66:283-292 (Pubitemid 46579626)
26. Luqumani RA, Exley AR, Kitas GD, Bacon PA (1997) Disease assessment and management of the vasculitides. Ballieres Clin Rheumatol 11:423-446 (Pubitemid 27296604)
27. Exley A, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the VDI. Arthritis Rheum 40:371-380
28. Exley A, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R (1998) Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 37:57-63
29. Vassilopoulos D, Calabrese LH (2002) Hepatitis C virus infection and vasculitis. Implications of antiviral and immunosuppressive therapies. Arthritis Rheum 46:585-97
30. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Font J (2003) Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. J Rheumatol 42:818-828 (Pubitemid 37220929)
31. Lamprecht P, Gause A, Gross WL (2000) Cryoglobulinemic vasculitis resistant to intermittent intravenous pulse cyclophosphamide therapy. Scand J Rheumatol 29:201-2 (Pubitemid 32014439)
32. Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P (2006) Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow up study. Arthritis Rheum 54:3696-706 (Pubitemid 44737183)
33. Conca P, Tarantino G (2009) Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy. World J Gastroentrol 15(19):2305-2308
34. Marrinho RT, Pinto RM, Santos ML, de Moura MC (2004) Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus. Liver Int 24:413-418 (Pubitemid 40484553)
35. Carreno V, Bartolome J, Castillo I, Quiroga JA (2008) Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol 18:139-157 (Pubitemid 351693493)
36. Pham TN, Michalak TI (2008) Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 14:2789-2793
37. Caudai C, Padula MG, Bastianoni I, Valensin PE, Shyamala V, Han J, Boggianno CA, Almi P (1998) Antibody testing and RTPCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons. Infection 26(3):151-154 (Pubitemid 28279248)
38. Monia F, Lamia B, Jalel B, Samira M, Amel S, Azza F (2005) Cryoglobulinemia in chronic hepatits C virus infection. About 76 cases. Tunis Méd 83(11):664-8
39. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ (1996) Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 104:25-31 (Pubitemid 26103408)
40. Narváez J, Biosca M, Perez-Vega C, Vilaseca-Momplet J (2003) Fulminant systemic vasculitis in a patient untreated asymptomatic chronic hepatitis C infection. Scand J Rheumatol 32:377-378
41. Sansonno D, Lauletta G, Nisi L, Gatti P, Pesola F, Pansini N, Dammaco F (2003) Nonenveloped HC core protein as constitutive antigen of cold precipitate immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol 133:275-282 (Pubitemid 36918603)
42. Sansonno D, Dammaco F (2005) Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227-236 (Pubitemid 40410068)
43. Lamprecht P, Moosig F, Gause A, Herlyn K, Csernok E, Hansen H, Gross WL (2001) Immunological and clinical follow-up of hepatitis C virus associated cryoglobulinaemic vasculitis. Ann Rheum Dis 60:385-390 (Pubitemid 32242753)
44. Levine JW, Gota C, Fessler BJ, Calabrese LH, Cooper SM (2005) Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 32:1164-7 (Pubitemid 40828106)
45. Thiele DL, Ducharme L, Cunningham MR et al (1996) Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Am J Gastroenterol 91:273-279